These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The crystal structure of the Argonaute2 PAZ domain reveals an RNA binding motif in RNAi effector complexes. Song JJ; Liu J; Tolia NH; Schneiderman J; Smith SK; Martienssen RA; Hannon GJ; Joshua-Tor L Nat Struct Biol; 2003 Dec; 10(12):1026-32. PubMed ID: 14625589 [TBL] [Abstract][Full Text] [Related]
3. Structure and nucleic-acid binding of the Drosophila Argonaute 2 PAZ domain. Lingel A; Simon B; Izaurralde E; Sattler M Nature; 2003 Nov; 426(6965):465-9. PubMed ID: 14615801 [TBL] [Abstract][Full Text] [Related]
4. Dicing and slicing: the core machinery of the RNA interference pathway. Hammond SM FEBS Lett; 2005 Oct; 579(26):5822-9. PubMed ID: 16214139 [TBL] [Abstract][Full Text] [Related]
5. Short interfering RNA strand selection is independent of dsRNA processing polarity during RNAi in Drosophila. Preall JB; He Z; Gorra JM; Sontheimer EJ Curr Biol; 2006 Mar; 16(5):530-5. PubMed ID: 16527750 [TBL] [Abstract][Full Text] [Related]
6. The Argonautes. Joshua-Tor L Cold Spring Harb Symp Quant Biol; 2006; 71():67-72. PubMed ID: 17381282 [TBL] [Abstract][Full Text] [Related]
7. Asymmetric RNA duplexes mediate RNA interference in mammalian cells. Sun X; Rogoff HA; Li CJ Nat Biotechnol; 2008 Dec; 26(12):1379-82. PubMed ID: 19029911 [TBL] [Abstract][Full Text] [Related]
8. Exploring chemical modifications for siRNA therapeutics: a structural and functional outlook. Shukla S; Sumaria CS; Pradeepkumar PI ChemMedChem; 2010 Mar; 5(3):328-49. PubMed ID: 20043313 [TBL] [Abstract][Full Text] [Related]
9. Competition potency of siRNA is specified by the 5'-half sequence of the guide strand. Yoo JW; Kim S; Lee DK Biochem Biophys Res Commun; 2008 Feb; 367(1):78-83. PubMed ID: 18164261 [TBL] [Abstract][Full Text] [Related]
10. Nucleic acid 3'-end recognition by the Argonaute2 PAZ domain. Lingel A; Simon B; Izaurralde E; Sattler M Nat Struct Mol Biol; 2004 Jun; 11(6):576-7. PubMed ID: 15156196 [TBL] [Abstract][Full Text] [Related]
11. Assembly and function of RNA silencing complexes. Sontheimer EJ Nat Rev Mol Cell Biol; 2005 Feb; 6(2):127-38. PubMed ID: 15654322 [TBL] [Abstract][Full Text] [Related]
13. Contributions of 3'-overhang to the dissociation of small interfering RNAs from the PAZ domain: molecular dynamics simulation study. Lee HS; Lee SN; Joo CH; Lee H; Lee HS; Yoon SY; Kim YK; Choe H J Mol Graph Model; 2007 Mar; 25(6):784-93. PubMed ID: 16959510 [TBL] [Abstract][Full Text] [Related]
14. Conversion of pre-RISC to holo-RISC by Ago2 during assembly of RNAi complexes. Kim K; Lee YS; Carthew RW RNA; 2007 Jan; 13(1):22-9. PubMed ID: 17123955 [TBL] [Abstract][Full Text] [Related]
15. The RNA-induced silencing complex is a Mg2+-dependent endonuclease. Schwarz DS; Tomari Y; Zamore PD Curr Biol; 2004 May; 14(9):787-91. PubMed ID: 15120070 [TBL] [Abstract][Full Text] [Related]
17. Illuminating the silence: understanding the structure and function of small RNAs. Rana TM Nat Rev Mol Cell Biol; 2007 Jan; 8(1):23-36. PubMed ID: 17183358 [TBL] [Abstract][Full Text] [Related]
19. Modified siRNAs for the study of the PAZ domain. Somoza A; Terrazas M; Eritja R Chem Commun (Camb); 2010 Jun; 46(24):4270-2. PubMed ID: 20485810 [TBL] [Abstract][Full Text] [Related]
20. Dissecting RNA-interference pathway with small molecules. Chiu YL; Dinesh CU; Chu CY; Ali A; Brown KM; Cao H; Rana TM Chem Biol; 2005 Jun; 12(6):643-8. PubMed ID: 15975509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]